Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Khối lượng lớn hút mỡ là một thủ tục có thể loại bỏ một lượng đáng kể của lớp mỡ dưới da, bao gồm cả chất béo từ các kho chất béo địa phương có nhiều tính năng sinh hóa gợi nhớ của những người được tìm thấy trong các mô mỡ nội tạng liên quan chặt chẽ với điều kiện của hội chứng X. | References 457 67.8 Concluding Remarks Large-volume liposuction is a procedure that can remove substantial amounts of subcutaneous fat including fat from the localized fat depot that has many biochemical features reminiscent of those found in the visceral adipose tissue that is tightly linked to the conditions of syndrome X. Liposuction and lipectomy have been used in some cases as adjuncts to more established bariatric surgery and recent developments have raised the possibility of the utility of liposuction as a primary surgical option for obesity management. The effects of large-volume liposuction on AVD risk still require intensive detailed investigation as there are two opposing theories as to what happens to AVD risk following this procedure. On the basis of clinical and animal data it appears that there is a threshold effect where removal of excessive subcutaneous fat may result in AVD risk improvement while removal of significantly greater amounts may result in deleterious effects. Clear definition of what determines this threshold in the individual patient is an important issue that needs to be resolved. The results of ongoing human and animal studies on this subject are eagerly awaited. Acknowledgement. This research was supported by the National Institute of Child Health and Human Development NIH ZO1 HD-00641 . References 1. American Heart Association. Heart and Stroke facts 1995 statistical supplements 1995 2. Gillum RF. New considerations in analyzing stroke and heart disease mortality trends the Year 2000 Age Standard and the International Statistical Classification of Diseases and Related Health Problems 10th Revision. Stroke 2002 33 1717-1722 3. Reaven GM. Role of insulin resistance in human disease syndrome X an expanded definition. Annu Rev Med 1993 44 121-131 4. Reaven GM. Syndrome X is one enough Am Heart J 1994 127 1439-1442 5. Reaven GM Lithell H Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and
